LFB Board of Directors

LFB is a majority State-owned limited company, currently wholly owned by the French State.

The Chairwoman of the Board of Directors of LFB SA is Corinne FAU.

Directors representing the French State:
Laurent SUSTER
Deputy Director of Energy Investments, State Investment Agency (APE)

Directors:
Pascale AUGÉ
Chairwoman of the Board of Directors of Inserm Transfert (SA)
Legal representative of Inserm Transfert on the Supervisory Board of Inserm Transfert Initiative (SAS)

Vincent BERJOT
Head of the General Economic and Financial Control Mission – French Ministry of the Economy and Finance

Jacques BROM
CEO of LFB

Nicolas CARTIER
CEO of Mérieux NutriSciences

Eric DRAPÉ
Executive Vice President of Teva Pharmaceuticals Ltd

Delphine MALLET
Deputy CEO in charge of Operations of DomusVi France

Loïc ROCARD
Chairman and CEO of TECHNICATOME

Director representing the employees:
Claire-Marie BERGUE
Head of Production, Arras Plant – LFB BIOMÉDICAMENTS

Vincent DENOIS
Director of IT Infrastructure & Operations, Les Ulis – LFB BIOMÉDICAMENTS

Marc LASCOMBES
Project Engineer, Lille – LFB BIOMÉDICAMENTS

Government Auditor:
Grégory EMERY
Deputy Director General of Health

Statutory Auditors:
Laurent DANIEL
PRICEWATERHOUSECOOPERS Audit
Laurent BRUN
CAILLIAU DEDOUIT and Associates

Economic and Financial Controller General:
Michel LEJEUNE